August 14, 2025 — Vision Marine Technologies (NASDAQ: VMAR), a leader in premium on-water experiences and owner of Florida-based dealership network Nautical Ventures, announced Nautical Ventures has signed a Letter of Intent with Nimbus Boats USA to exclusively distribute Nimbus powerboats on Florida’s West Coast. The agreement, expected to be finalized by March 31, 2026, would authorize Nautical Ventures to promote, sell and service Nimbus’s Tender, Commuter, Weekender and Coupe series beginning August 1, 2025.
August 14, 2025 — The Trump administration’s price support strategy represents a significant shift in U. S.
August 14, 2025 — ECGI Holdings (OTC: ECGI), announced that its investment arm, Uplist Ventures, has made a strategic investment in AuraChat. ai, a sales and marketing automation platform powered by more than 25 proprietary AI models.
August 14, 2025 — July 2025 rollout delivers human-quality outreach without SDR teams, handling both transactional and consultative sales AI-in-marketing market forecast to grow from $20. 44 billion in 2024 to $82.
August 14, 2025 — SuperCom (NASDAQ: SPCB), a global provider of secured e-Government, IoT, and cybersecurity solutions, reported Q2 2025 revenue of $7. 14 million, with gross margin rising to 59.
August 14, 2025 — Multi-agent AI infrastructure partnership with IQSTEL addresses the fundamental challenge of isolated marketing data across platforms, creating unified intelligence for campaign optimization Retina. ai acquisition brings customer lifetime value prediction and churn forecasting capabilities to ONAR’s client roster, including brands like Unilever and Dollar Shave Club Three-phase deployment strategy transforms agency operations from reactive optimization to proactive performance enhancement through interconnected AI agents Marketing executives face a paradox that undermines billions in annual advertising investment.
August 14, 2025 — Four-property Nevada portfolio anchored by the 2-million-ounce Santa Fe Mine positions Lahontan in North America’s most mining-friendly jurisdiction during gold’s institutional transformation Walker Lane geological corridor continues attracting major acquisitions, with AngloGold Ashanti’s recent C$152 million Augusta Gold purchase highlighting regional consolidation trends As Gold Surges, Junior Miners Offer Unmatched Leverage Gold recently soared past $3,000 per ounce and briefly touched a record high of $3,500, driven by persistent inflation, geopolitical instability, and rising central bank demand. As traditional safe-haven assets regain favor, institutional capital is once again eyeing gold.
August 14, 2025 — CNS Pharmaceuticals (NASDAQ: CNSP), a biopharma company developing novel treatments for primary and metastatic cancers in the brain and central nervous system, announced it will present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech, taking place virtually Aug. 19–21, 2025.
August 14, 2025 — NextPlat (NASDAQ: NXPL, NXPLW), a global consumer products and services company in healthcare and technology, reported Q2 2025 revenue of $13. 2 million versus $17.
August 14, 2025 — FingerMotion (NASDAQ: FNGR) announced that its subsidiary, Shanghai JiuGe Information Technology Co. , Ltd.
August 14, 2025 — The rise of AI has triggered an exponential growth in data-center construction and expansion, driving copper demand to unprecedented levels. Bell Canada has announced the construction of six new AI data centers in British Columbia, including one in Merritt, British Columbia, strategically located near Nicola Mining.
August 14, 2025 — Newton Golf Company (NASDAQ: NWTG), a technology-forward golf company delivering physics-based performance innovations, reported Q2 2025 revenue of $2. 1 million, up 154% from $813,000 in the year-ago quarter, with gross margin improving to 67.
August 14, 2025 — Clene (NASDAQ: CLNN), a late clinical-stage biopharma company developing treatments for neurodegenerative diseases, reported Q2 2025 results and said it has sufficient cash runway into Q1 2026. The company plans to meet with the FDA this quarter to review survival data for lead candidate CNM-Au8 in amyotrophic lateral sclerosis (ALS) and is preparing analyses of NIH-sponsored Expanded Access Program neurofilament light biomarker data, expected in Q4.
August 14, 2025 — Lantern Pharma (NASDAQ: LTRN), a clinical-stage biopharma company leveraging its RADR(R) AI/ML platform for oncology drug discovery and development, announced Q2 2025 results and portfolio updates. The company reported complete responses in patients across two trials — LP-300 in advanced NSCLC and LP-284 in refractory diffuse large B-cell lymphoma — along with completion of LP-184 Phase 1a enrollment, positioning it for Phase 1b/2 studies in high-value indications.
August 14, 2025 — Vietnamese electric vehicle firm VinFast has advanced its entry into the Indian market via an agreement with BatX Energies, the largest lithium-ion battery recycling firm in India, to recycle electric vehicle batteries in the country. It remains to be seen how successful the recycling effort started by VinFast in India will be, and whether this will result in viable input sources for affiliated verticals like battery makers, such a PowerBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: 103)… Read More>> About GreenCarStocks GreenCarStocks (“GCS”) is a specialized communications platform with a focus on electric vehicles (“EVs”) and the green energy sector.
August 14, 2025 — Earlier this week, President Donald Trump posted that he wouldn’t impose tariffs on gold. This announcement was welcomed by the international bullion markets, as it resolved uncertainty that the precious metal would be entangled in the ongoing international trade tensions.
August 14, 2025 — It is easy to shrug off forgetfulness or a headache as stress. However, this isn’t always the case as those symptoms could point to the possibility of a tumor in the brain.
August 14, 2025 — The launch of Chinese DeepSeek AI sent shockwaves through Silicon Valley earlier this year. Practically overnight, its flagship model, DeepSeek-R1, soared to the top of the U.
August 14, 2025 — Soligenix (NASDAQ: SNGX), a late-stage biopharma company developing treatments for rare diseases, reported Q2 2025 results and recent milestones. The company expects top-line Phase 2a results for SGX302 in mild-to-moderate psoriasis before year-end, along with continued updates from its investigator-initiated study of HyBryte(TM) for early-stage cutaneous T-cell lymphoma (CTCL).
August 14, 2025 — Cybin (NYSE American: CYBN) (Cboe CA: CYBN), a clinical-stage neuropsychiatry company developing next-generation mental health treatments, reported unaudited Q1 2025 results and key program updates. The company gained European Clinical Trial Application and UK MHRA approval to begin EMBRACE, expanding its multinational Phase 3 PARADIGM program of CYB003 for adjunctive treatment of major depressive disorder to approximately 550 participants.
